INTECH Investment Management’s Regeneron Pharmaceuticals REGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$7.2M Buy
9,319
+2,314
+33% +$1.77M 0.07% 253
2025
Q4
$5.41M Sell
7,005
-277
-4% -$188K 0.05% 343
2025
Q3
$4.09M Sell
7,282
-613
-8% -$347K 0.04% 445
2025
Q2
$4.14M Sell
7,895
-90
-1% -$50.2K 0.04% 404
2025
Q1
$5.06M Sell
7,985
-6,356
-44% -$4.37M 0.05% 321
2024
Q4
$10.2M Buy
14,341
+2,438
+20% +$2.05M 0.1% 166
2024
Q3
$12.5M Sell
11,903
-3,240
-21% -$3.61M 0.14% 137
2024
Q2
$15.9M Buy
15,143
+2,245
+17% +$2.18M 0.2% 91
2024
Q1
$12.4M Sell
12,898
-5,695
-31% -$5.42M 0.17% 114
2023
Q4
$16.3M Buy
18,593
+10,104
+119% +$8.32M 0.24% 97
2023
Q3
$6.99M Buy
8,489
+2,582
+44% +$2.03M 0.1% 208
2023
Q2
$4.24M Sell
5,907
-33,018
-85% -$25.5M 0.04% 295
2023
Q1
$32M Sell
38,925
-11,751
-23% -$8.86M 0.26% 98
2022
Q4
$36.6M Buy
50,676
+7,000
+16% +$5.17M 0.27% 102
2022
Q3
$30.1M Sell
43,676
-4,700
-10% -$2.96M 0.23% 116
2022
Q2
$28.6M Buy
+48,376
New +$31.4M 0.16% 160

Other funds holding REGN